International Conference and Annual Meeting

April 22–24, 2018 | Honolulu, Hawaii, USA | #ICAM2018

Plenary Speakers

Plenary II: Beta Gamma Sigma International Honoree

Lynne_DoughtieLynne Doughtie, Chairman and Chief Executive Officer, KPMG LLP

Lynne Doughtie is chairman and chief executive officer of KPMG LLP — one of the world’s leading professional services firms providing tax, audit and advisory services. She also is a member of KPMG’s Global Board and Executive Committee. In her role, Lynne leads more than 30,000 partners and professionals across the United States. Lynne drives KPMG’s inclusive and purpose-driven culture, which is defined by a commitment to corporate responsibility and maintaining the highest levels of professionalism and quality in KPMG’s client service and support of the capital markets. Previously, Lynne served as vice chair of KPMG’s Advisory business from 2011 to 2015, establishing it as the firm’s fastest growing business. She also oversaw the expansion of KPMG’s capabilities in innovative services and solutions, including information security, strategy, digital/mobile, and transformation. Lynne began her career in KPMG’s Audit practice in 1985 and has served in a number of national, regional, and global leadership roles, including lead partner for several major clients. In recognition of her professional accomplishments, Lynne has received numerous accolades, including Fortune magazine’s Most Powerful Women in Business, Crain’s New York Business magazine’s 50 Most Powerful Women in New York, Accounting Today magazine’s Top 100 Most Influential People, the National Association of Corporate Directors’ 100 most influential people in the boardroom, and “Woman of Achievement” by the National Association of Female Executives. Lynne lends her time and expertise to various organizations. She is a governing board member for the Center for Audit Quality and a member of The Committee of 200.  She also serves as a board member for NAF, the Partnership for New York City, and LUNGevity. Lynne received her Bachelor of Science degree in accounting from the Pamplin College of Business at Virginia Tech. She remains an active alumnus and serves as a member of the Advisory Board for Pamplin College of Business and as a member of Pamplin’s Accounting and Information Systems Advisory Board. In 2007, she was awarded the Distinguished Alumnus Award for outstanding career accomplishments and contributions to the college. Lynne earned CPA certification in Virginia and New York and is a member of the American Institute of Certified Public Accountants. 

Plenary III

Paul_ZakPaul Zak, scientist, entrepreneur and author of Trust Factor and The Moral Molecule

Paul Zak’s two decades of research have taken him from the Pentagon to Fortune 50 boardrooms to the rain forest of Papua New Guinea.  All this in a quest to understand the neuroscience of human connection, human happiness, and effective teamwork.  His academic lab and companies he has started develop and deploy neuroscience technologies to solve real problems faced by real people. His book, Trust Factor: The Science of Creating High Performance Companies (2017), uses neuroscience to measure and manage organizational cultures to inspire teamwork and accelerate business outcomes.  His 2012 book, The Moral Molecule: The Source of Love and Prosperity, recounted his unlikely discovery of the neurochemical oxytocin as the key driver of trust, love, and morality that distinguish our humanity.   In another obsession, Paul’s group uses neuroscience to quantify the impact of movies, advertising, stories, and consumer experiences.  Along the way, he has help start several transdisciplinary fields, including neuroeconomics, neuromanagement, and neuromarketing. Paul is the founding Director of the Center for Neuroeconomics Studies and Professor of Economics, Psychology and Management at Claremont Graduate University. He has degrees in mathematics and economics from San Diego State University, a Ph.D. in economics from University of Pennsylvania, and post-doctoral training in neuroimaging from Harvard.